Kim S, Wuthrick E, Blakaj D, Eroglu Z, et al. Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial. Lancet 2022;400:1008-1019.
PMID: 36108657